Literature DB >> 7532432

Regulation of apoptosis and T cell activation by Fas-specific mAb.

M R Alderson1, T W Tough, S Braddy, T Davis-Smith, E Roux, K Schooley, R E Miller, D H Lynch.   

Abstract

Fas was initially described as a molecule expressed on the surface of certain cell lines that could mediate programmed cell death (apoptosis) subsequent to ligation by specific mAb. To determine whether mAb to other epitopes on the Fas molecule might mediate other functions, we generated a panel of mAb to the extracellular portion of human Fas. Significant lysis of Fas-expressing target cells was only observed when the new mAb were first bound to a solid-phase support and not when the mAb were added in solution. However, several of these mAb inhibited the killing of target cells induced by the prototypic Fas-specific mAb, CH-11. Those mAb that inhibited apoptosis of target cells mediated by the CH-11 mAb also blocked lysis of target cells mediated by cells expressing Fas ligand. Finally, some of the Fas-specific mAb were found to co-stimulate proliferation of peripheral blood T cells in the presence of immobilized CD3 mAb. Thus, the data indicate the existence of a complex set of interactions mediated by Fas in both normal and transformed lymphoid cells that may have important implications regarding the role(s) of this molecule in regulation of immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532432     DOI: 10.1093/intimm/6.11.1799

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  25 in total

Review 1.  Receptors and ligands that mediate activation-induced death of T cells.

Authors:  M R Alderson; D H Lynch
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Dichotomy between naïve and memory CD4(+) T cell responses to Fas engagement.

Authors:  J Desbarats; T Wade; W F Wade; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.

Authors:  K G Smith; A Strasser; D L Vaux
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

4.  HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis.

Authors:  M Boirivant; M Viora; L Giordani; A L Luzzati; A M Pronio; C Montesani; O Pugliese
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

5.  Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line.

Authors:  G S D Reid; S Bharya; H-G Klingemann; K R Schultz
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells.

Authors:  J Desbarats; J H Freed; P A Campbell; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.

Authors:  Quanfu Mao; Sravanthi Gundavarapu; Chintan Patel; Amy Tsai; Francois I Luks; Monique E De Paepe
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

8.  Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.

Authors:  C R Casella; E L Rapaport; T H Finkel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 9.  Cellular FLICE-inhibitory protein: an attractive therapeutic target?

Authors:  Olivier Micheau
Journal:  Expert Opin Ther Targets       Date:  2003-08       Impact factor: 6.902

10.  Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes.

Authors:  A D Badley; J A McElhinny; P J Leibson; D H Lynch; M R Alderson; C V Paya
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.